Master Delivering on the promise of personalized breast cancer therapy - May 17, 2023 CAR-NKT cell therapy shows promising results against neuroblastoma in phase 1 clinical trial - May 15, 2023 Study reveals epigenetic vulnerability of acute myeloid leukemia - Apr 3, 2023 Baylor receives more than $5.8 million in CPRIT funding - Feb 16, 2023 Study helps explain severe graft-versus-host disease and potential solution - Feb 2, 2023 Study unveils molecular pathway of metastatic cancer cells - Feb 1, 2023 Boeynaems awarded CPRIT grant to study stress response in cells - Jan 11, 2023 Oops. After ten years and 1,000 studies, epigeneticists uncover trouble in their tool box - Jan 11, 2023 A promising drug delivery method could replace injections with pills - Jan 4, 2023 Preoperative immunotherapy for mesothelioma shows favorable outcomes - Dec 13, 2022 Oxytocin drives development of neural connections in adult-born neurons - Dec 9, 2022 Dissemination of bone metastasis linked with bone remodeling - Oct 26, 2022 Get moving after breast cancer surgery - Oct 25, 2022 Researchers uncover how breast cancer cells become resistant to therapy - Oct 17, 2022 A novel strategy to suppress prostate cancer growth - Oct 17, 2022 Know your risk for breast cancer - Oct 13, 2022 Baylor College of Medicine recruiting volunteers for pancreatic cancer clinical trial - Oct 5, 2022 NCI renews lymphoma SPORE grant for Center for Cell and Gene Therapy - Oct 3, 2022 Promising approach to mitigate complications of leukemia treatment - Sep 27, 2022 Researchers identified markers of chemotherapy resistance in triple negative breast cancer - Aug 24, 2022 Baylor receives NCI grant to study liver cancer risk and prevention - Aug 4, 2022 Broadly diverse genomes study reveals new susceptibility genetic variants for lung cancer - Aug 1, 2022 CPTAC renews funding for proteogenomics research at Baylor - Jun 28, 2022 A potentially more effective treatment for HER2 mutant metastatic breast cancer - Jun 24, 2022 Anti-aging clues lurk in lysosomes, the recycling centers of the cell - Jun 10, 2022 A promising combination therapy for triple-negative breast cancer - Apr 27, 2022 Two distinct tuberculosis subtypes IDed – implications for personalized therapy - Mar 30, 2022 Study shows long-term safety of genetically modified immune effector cells - Mar 30, 2022 SRC-3 is a key regulator of the 12-hour clock - Mar 9, 2022 Baylor receives more than $15.6 million in CPRIT funding - Feb 17, 2022 Pagination Previous page Current page 1 Page 2 Page 3 Page 4 Page 5 Next page
